Gollob Jared sold KYMR
December 8, 2025 · Form 4 insider transaction
Gollob Jared sold 1,400 shares of Kymera Therapeutics, Inc. at $92.19 per share, a transaction worth $129.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,400
Price
$92.19
Total value
$129.1K
InsiderGollob Jared
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 8, 2025
Filing dateDecember 8, 2025
Shares owned after109,992
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 2, 2025 adopted by the reporting person.